VAN DEN BOOGAARD, F. E., BRANDS, X., SCHULTZ, M. J., LEVI, M., ROELOFS, J. J. T. H., VAN 'T VEER, C., & VAN DER POLL, T. (2011). Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti‐inflammatory and antimicrobial effects in murine pneumococcal pneumonia. Journal of thrombosis and haemostasis, 9(1), 122-132. https://doi.org/10.1111/j.1538-7836.2010.04089.x
Citácia podle Chicago (17th ed.)VAN DEN BOOGAARD, F. E., X. BRANDS, M. J. SCHULTZ, M. LEVI, J. J. T. H. ROELOFS, C. VAN 'T VEER, a T. VAN DER POLL. "Recombinant Human Tissue Factor Pathway Inhibitor Exerts Anticoagulant, Anti‐inflammatory and Antimicrobial Effects in Murine Pneumococcal Pneumonia." Journal of Thrombosis and Haemostasis 9, no. 1 (2011): 122-132. https://doi.org/10.1111/j.1538-7836.2010.04089.x.
Citácia podľa MLA (8th ed.)VAN DEN BOOGAARD, F. E., et al. "Recombinant Human Tissue Factor Pathway Inhibitor Exerts Anticoagulant, Anti‐inflammatory and Antimicrobial Effects in Murine Pneumococcal Pneumonia." Journal of Thrombosis and Haemostasis, vol. 9, no. 1, 2011, pp. 122-132, https://doi.org/10.1111/j.1538-7836.2010.04089.x.